AstraZeneca, Incyte in Lung Cancer Clinical Trial Pact
By
AstraZeneca and MedImmune, its global biologics research and development arm, have expanded their immuno-oncology clinical collaboration with Incyte, a Wilmington, Delaware-based biopharmaceutical company. Under the agreement, the companies will evaluate…